tenk.fyi

Atara Biotherapeutics, Inc.

ATRANasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$120.8M

6.3% YoY

Net Income

$32.7M

138.3% YoY

EPS

$2.57

122.5% YoY

Cash

$8.5M

66.1% YoY

FY 2025 · As of 2025-12-31